作者:Michael Bös、Heinz Stadler、Jürgen Wichmann、François Jenck、James R. Martin、Jean-Luc Moreau、Andrew J. Sleight
DOI:10.1002/hlca.19980810306
日期:——
Based on O-methylasparvenone (1), a N-free 5HT2C antagonist with moderate affinity (pKi = 6.7), derivatives bearing dimethylamino (7), (dimethylamino)methyl (17, 18, 21, and 22), and aminomethyl substituents (26) in place of the benzylic OH group of 1 as well as pyrrolidine- (33) and piperidine-fused derivatives (29, 43, and 45) were synthesized. In contrast to the lead structure 1, these new ligands
基于ø -methylasparvenone(1),其N-自由5HT 2 ç拮抗剂与中等亲和力(对ķ我= 6.7),衍生物轴承二甲基氨基(7),(二甲基氨基)甲基(17,18,21,和22),和氨基甲基的取代基(26)代替苄基的OH基团中的1以及吡咯烷(33)和哌啶稠合衍生物(29,43,和45)的合成。与引线结构1相反这些新的配体在大鼠体内具有活性。三轮车33和45显示出对5HT 2 C受体的高亲和力(p K i = 8)。